1.800.KIDS DOC | 1.800.543.7362

Fei Chu, MD, PhD

Fei Chu, MD, PhD

Research Assistant Professor of Surgery, Northwestern University Feinberg School of Medicine

Education & Training

Education: Henderson State University, Arkadelphia, AR, 1992,

Postgraduate Training: Beijing Medical University, Beijing, China, Pathology, 1998

Research

Research Interests: Aging; cancer biology; metabolism; molecular biology; pediatrics; stem cells

Publications

Most recent publications

Mesenchymal change and drug resistance in neuroblastoma J Surg Res193 (1): 279-88
Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma J Pediatr Surg49 (6): 981-4
Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics Cell Death Dis4e740
The effect of vorinostat on the development of resistance to doxorubicin in neuroblastoma PLoS One7 (7): e40816
Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma J Pediatr Surg47 (6): 1267-71
The role of nerve growth factor in caspase-dependent apoptosis in human BE(2)C neuroblastoma J Pediatr Surg46 (6): 1191-6
Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism Am J Physiol Cell Physiol296 (1): C65-74
Role of the proteolytic hierarchy between cathepsin L, cathepsin D and caspase-3 in regulation of cellular susceptibility to apoptosis and autophagy Biochim Biophys Acta1783 (12): 2294-300
Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway Aging Cell7 (4): 516-25
Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent Angiogenesis11 (3): 269-76

Call for Insurance information: 1.800.543.7362